Hepatitis C has more treatment options than ever before.
Hepatitis C is a contagious liver infection that can range in severity from a mild illness lasting a few weeks to a serious, lifelong condition. According to the CDC, an estimated 2.7 to 3.9 million people in the United States have chronic hepatitis C.
In the U.S., baby boomers account for more than 75% of all patients with hepatitis C; however, today, most people become infected with hepatitis C virus (HCV) by sharing needles or other equipment to inject drugs.
Chronic hepatitis C can cause serious complications including cirrhosis, liver failure and liver cancer. Hepatitis C is the leading cause of liver transplantation and contributes to more than 10,000 deaths annually in the U.S. It also causes other extra-hepatic manifestations, such as neurologic, endocrine, and cardiovascular effects.
|Read Full Article: Evolving hepatitis C pipeline offers hope to patients | Managed Healthcare Executive|